Trademark: 79278237
Status Date
Tuesday, September 1, 2020
Registration Number
6138770
Registration Date
Tuesday, September 1, 2020
Filing Date
Monday, December 2, 2019
Published for Opposition
Tuesday, June 16, 2020
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; biological preparations for the treatment of bacterial infections, viral infections, inflammatory disorders, fungal infections, cardiovascular diseases and disorders, dermatological conditions, respiratory diseases and disorders, central nervous system diseases and disorders, gastrointestinal diseases and disorders, kidney diseases, diabetes, hypertension, skin disorders, cancer and tumors, allergies, bone diseases, diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the Musculo-skeletal system and the genitourinary system; biological preparations for use in hematology and in tissue and organ transplantation; biological preparations for prevention and treatment of eye diseases and conditions; biological preparations for the prevention and treatment of heart rhythm disorders; biological preparations for the prevention and treatment of immune system related diseases and disorders and stem cells for pharmaceutical and medical use
44 Collection and preservation of blood; collection and preservation services for tissue and cells, namely, collection and banking of umbilical cord tissue perivascular stem cells; medical diagnostic services; medical treatment services; provision of medical information and data for diagnosis and medical treatment
Jan 23, 2021
Final Decision Transaction Processed By Ib
Dec 31, 2020
Final Disposition Notice Sent To Ib
Dec 31, 2020
Final Disposition Processed
Dec 1, 2020
Final Disposition Notice Created, To Be Sent To Ib
Sep 1, 2020
Registered-Principal Register
Jun 16, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 16, 2020
Published For Opposition
May 27, 2020
Notification Of Notice Of Publication E-Mailed
May 7, 2020
Assigned To Lie
Apr 29, 2020
Approved For Pub - Principal Register
Apr 24, 2020
Teas/Email Correspondence Entered
Apr 23, 2020
Correspondence Received In Law Office
Apr 23, 2020
Teas Response To Office Action Received
Apr 10, 2020
Refusal Processed By Ib
Mar 18, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Mar 18, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 18, 2020
Teas Change Of Correspondence Received
Mar 18, 2020
Teas Change Of Domestic Representatives Address
Mar 18, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 18, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 18, 2020
Teas Change Of Owner Address Received
Mar 18, 2020
Refusal Processed By Mpu
Feb 28, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Feb 27, 2020
Non-Final Action Written
Feb 27, 2020
Assigned To Examiner
Feb 18, 2020
Application Filing Receipt Mailed
Feb 12, 2020
New Application Office Supplied Data Entered In Tram
Feb 11, 2020
Limitation From Original Application Entered
Feb 6, 2020
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
